Summary
GlobalData's Medical Devices sector report, “Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Bariatric Surgery Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bariatric Surgery Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Bariatric Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bariatric Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Bariatric Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.
Companies Mentioned
3DT Holdings LLC
Allurion Technologies, Inc.
Applied Medical Resources Corporation
BAROnova, Inc.
BFKW, LLC
Boston Scientific Corp
C. R. Bard Inc
Columbia University
EndoRetics Inc.
EndoVx Inc
Gelesis Inc
GI Dynamics Inc
Hebrew University of Jerusalem
Innovia LLC
Johns Hopkins University
Mayo Clinic
Medi-Globe GmbH
MetaModix, Inc
Mmtc, Inc.
Nanyang Technological University
National University of Singapore
Precision Medical Devices Inc
ReShape Lifesciences Inc
Satiety Inc
Sensate LLC
Silhouette Medical, Inc.
SLIMEDICS LTD
Spatz FGIA, Inc
The Sheikh Zayed Institute for Pediatric Surgical Innovation
TransEnterix Inc
Tulip Medical Ltd.
UAS LifeSciences LLC
University of Florida
University of Miami
ValenTx, Inc.
Vibrynt, Inc.
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Bariatric Surgery Devices Overview 9
3 Products under Development 10
3.1 Bariatric Surgery Devices - Pipeline Products by Stage of Development 10
3.2 Bariatric Surgery Devices - Pipeline Products by Segment 11
3.3 Bariatric Surgery Devices - Pipeline Products by Territory 12
3.4 Bariatric Surgery Devices - Pipeline Products by Regulatory Path 13
3.5 Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 14
3.6 Bariatric Surgery Devices - Ongoing Clinical Trials 15
4 Bariatric Surgery Devices - Pipeline Products under Development by Companies 16
4.1 Bariatric Surgery Devices Companies - Pipeline Products by Stage of Development 16
4.2 Bariatric Surgery Devices - Pipeline Products by Stage of Development 18
5 Bariatric Surgery Devices Companies and Product Overview 20
5.1 3DT Holdings LLC Company Overview 20
5.2 Allurion Technologies, Inc. Company Overview 21
5.3 Applied Medical Resources Corporation Company Overview 24
5.4 BAROnova, Inc. Company Overview 25
5.5 BFKW, LLC Company Overview 26
5.6 Boston Scientific Corp Company Overview 27
5.7 C. R. Bard Inc Company Overview 28
5.8 Columbia University Company Overview 29
5.9 EndoRetics Inc. Company Overview 30
5.10 EndoVx Inc Company Overview 31
5.11 Gelesis Inc Company Overview 32
5.12 GI Dynamics Inc Company Overview 34
5.13 Hebrew University of Jerusalem Company Overview 38
5.14 Innovia LLC Company Overview 39
5.15 Johns Hopkins University Company Overview 41
5.16 Mayo Clinic Company Overview 42
5.17 Medi-Globe GmbH Company Overview 43
5.18 MetaModix, Inc Company Overview 44
5.19 Mmtc, Inc. Company Overview 46
5.20 Nanyang Technological University Company Overview 47
5.21 National University of Singapore Company Overview 48
5.22 Precision Medical Devices Inc Company Overview 49
5.23 ReShape Lifesciences Inc Company Overview 50
5.24 Satiety Inc (Inactive) Company Overview 53
5.25 Sensate LLC Company Overview 54
5.26 Silhouette Medical, Inc. Company Overview 55
5.27 SLIMEDICS LTD Company Overview 56
5.28 Spatz FGIA, Inc Company Overview 57
5.29 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 58
5.30 TransEnterix Inc Company Overview 59
5.31 Tulip Medical Ltd. Company Overview 60
5.32 UAS LifeSciences LLC Company Overview 61
5.33 University of Florida Company Overview 62
5.34 University of Miami Company Overview 63
5.35 ValenTx, Inc. Company Overview 64
5.36 Vibrynt, Inc. (Inactive) Company Overview 67
6 Bariatric Surgery Devices- Recent Developments 68
6.1 Jul 17, 2018: BAROnova Announces Submission of Premarket Approval Application to the U.S. FDA for the TransPyloric Shuttle Device Intended for the Treatment of Obesity 68
6.2 Jul 16, 2018: Surefire Medical Names Anil Singhal As Board Director 68
6.3 Jul 04, 2018: NHS EndoBarrier Service Shows Patients Maintain Treatment Effect Six Months Post Explant 69
6.4 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 70
6.5 Jun 27, 2018: ReShape Lifesciences Announces Acceptance of Abstract to be Presented at IFSO Annual Conference 71
6.6 Jun 19, 2018: ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest 71
6.7 Jun 06, 2018: FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon 71
6.8 Jun 05, 2018: Harry Leider, Former Chief Medical Officer of Walgreens, Joins Gelesis as Chief Medical Officer, and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, Joins the Gelesis Board of Directors 72
6.9 Jun 05, 2018: Apollo Endosurgery Announces Presentation of Mayo Clinic’s Clinical Study of ORBERA Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis at Digestive Disease Week 2018 73
6.10 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 75
6.11 Jun 04, 2018: Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA Intragastric Balloon System 76
6.12 Jun 04, 2018: Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week 2018 titled: “Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon” 77
7 Appendix 164
7.1 Methodology 164
7.2 About GlobalData 167
7.3 Contact Us 167
7.4 Disclaimer 167
1.1 List of Tables
Table 1: Bariatric Surgery Devices - Pipeline Products by Stage of Development 11
Table 2: Bariatric Surgery Devices - Pipeline Products by Segment 12
Table 3: Bariatric Surgery Devices - Pipeline Products by Territory 13
Table 4: Bariatric Surgery Devices - Pipeline Products by Regulatory Path 14
Table 5: Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 15
Table 6: Bariatric Surgery Devices - Ongoing Clinical Trials 16
Table 7: Bariatric Surgery Devices Companies - Pipeline Products by Stage of Development 17
Table 8: Bariatric Surgery Devices - Pipeline Products by Stage of Development 19
Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 10: Gastric Sleeve Magnetic Implant - Product Status 21
Table 11: Gastric Sleeve Magnetic Implant - Product Description 21
Table 12: Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 13: Elipse Balloon - Product Status 22
Table 14: Elipse Balloon - Product Description 22
Table 15: Allurion Technologies, Inc. - Ongoing Clinical Trials Overview 23
Table 16: Elipse Balloon - A Randomized, Multi-center, Phased, Pivotal Safety and Efficacy Study Comparing the Elipse Gastric Balloon System Versus Sham for the Treatment of Obese Adults 24
Table 17: Elipse Balloon - Pilot Trial of the Elipse Intragastric Balloon System for the Treatment of Overweight and Obese Individuals 24
Table 18: Elipse Balloon - The BALLOON- (Balloon Treatment for Obesity in Norway) Pilot Study 24
Table 19: Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 25
Table 20: Next Generation Bariatric Surgical Device - Product Status 25
Table 21: Next Generation Bariatric Surgical Device - Product Description 25
Table 22: BAROnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 23: TransPyloric Shuttle Device - Product Status 26
Table 24: TransPyloric Shuttle Device - Product Description 26
Table 25: BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview 27
Table 26: Full Sense - Product Status 27
Table 27: Full Sense - Product Description 27
Table 28: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
Table 29: TERIS - Product Status 28
Table 30: TERIS - Product Description 28
Table 31: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 32: Restore Suturing System - Product Status 29
Table 33: Restore Suturing System - Product Description 29
Table 34: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 30
Table 35: Gastric Bypass Shunt - Product Status 30
Table 36: Gastric Bypass Shunt - Product Description 30
Table 37: EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 38: Endoretics Device - Product Status 31
Table 39: Endoretics Device - Product Description 31
Table 40: EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 41: EndoVx Device - Product Status 32
Table 42: EndoVx Device - Product Description 32
Table 43: Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 44: Gelesis100 - Product Status 33
Table 45: Gelesis100 - Product Description 33
Table 46: Gelesis100 - Pediatric - Product Status 34
Table 47: Gelesis100 - Pediatric - Product Description 34
Table 48: GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 49: EndoBarrier Flow Restrictor - Product Status 35
Table 50: EndoBarrier Flow Restrictor - Product Description 35
Table 51: EndoBarrier Liner With EndoBarrier Restrictor - Product Status 36
Table 52: EndoBarrier Liner With EndoBarrier Restrictor - Product Description 36
Table 53: GI Dynamics Inc - Ongoing Clinical Trials Overview 37
Table 54: EndoBarrier Liner With EndoBarrier Restrictor - Endoscopic Treatment of Obesity with a Duodenal-jejunal Bypass Sleeve: Does Impairment of Fat Absorption Explain Weight Loss 38
Table 55: EndoBarrier Liner With EndoBarrier Restrictor - Randomization to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity) 38
Table 56: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 39
Table 57: MetaboShield - Product Status 39
Table 58: MetaboShield - Product Description 39
Table 59: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 40
Table 60: Gastric Balloon - Product Status 40
Table 61: Gastric Balloon - Product Description 40
Table 62: Gastric Sleeve - Product Status 41
Table 63: Gastric Sleeve - Product Description 41
Table 64: Laparoscopic Band - Product Status 41
Table 65: Laparoscopic Band - Product Description 41
Table 66: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 42
Table 67: Image-guided Bariatric Arterial Embolization Device - Product Status 42
Table 68: Image-guided Bariatric Arterial Embolization Device - Product Description 42
Table 69: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 43
Table 70: Endoscopic Therapy Device - Obesity - Product Status 43
Table 71: Endoscopic Therapy Device - Obesity - Product Description 43
Table 72: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 44
Table 73: Medi-Globe Gastric Balloon - Product Status 44
Table 74: Medi-Globe Gastric Balloon - Product Description 44
Table 75: MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 76: Endosleeve - Product Status 45
Table 77: Endosleeve - Product Description 45
Table 78: Second Generation Liner Device - Product Status 46
Table 79: Second Generation Liner Device - Product Description 46
Table 80: Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 81: Wearable BAT Monitor - Product Status 47
Table 82: Wearable BAT Monitor - Product Description 47
Table 83: Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 48
Table 84: Gastric Clip - Product Status 48
Table 85: Gastric Clip - Product Description 48
Table 86: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 49
Table 87: Weight Management Device - Product Status 49
Table 88: Weight Management Device - Product Description 49
Table 89: Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 90: Flow Control Device - Obesity - Product Status 50
Table 91: Flow Control Device - Obesity - Product Description 50
Table 92: ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 93: ReShape Vest - Product Status 51
Table 94: ReShape Vest - Product Description 51
Table 95: ReShape Lifesciences Inc - Ongoing Clinical Trials Overview 52
Table 96: ReShape Vest - Safety and Performance Study for the Gastric Vest System: Gastric Vest CE Mark trial 53
Table 97: Satiety Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54
Table 98: TOGA System - Product Status 54
Table 99: TOGA System - Product Description 54
Table 100: Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview 55
Table 101: Sensate Anchored Gastric Device - Product Status 55
Table 102: Sensate Anchored Gastric Device - Product Description 55
Table 103: Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
Table 104: nObese Device - Product Status 56
Table 105: nObese Device - Product Description 56
1.2 List of Figures
Figure 1: Bariatric Surgery Devices - Pipeline Products by Stage of Development 11
Figure 2: Bariatric Surgery Devices - Pipeline Products by Segment 12
Figure 3: Bariatric Surgery Devices - Pipeline Products by Territory 13
Figure 4: Bariatric Surgery Devices - Pipeline Products by Regulatory Path 14
Figure 5: Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 15
Figure 6: Bariatric Surgery Devices - Ongoing Clinical Trials 16
